Mouton Johannes P, Blockman Marc, Sekaggya-Wiltshire Christine, Semakula Jerome, Waitt Catriona, Pirmohamed Munir, Cohen Karen
Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda.
Br J Clin Pharmacol. 2021 Aug;87(8):3056-3068. doi: 10.1111/bcp.14768. Epub 2021 Mar 10.
Patients in sub-Saharan Africa generally have poor anticoagulation control. We review the potential reasons for this poor control, as well as the potential solutions. Challenges include the affordability and centralisation of anticoagulation care, problems with access to medicines and international normalised ratio monitoring, the lack of locally validated standardized dosing protocols, and low levels of anticoagulation knowledge among healthcare workers and patients. Increasing numbers of patients will need anticoagulation in the future because of the increasing burden of noncommunicable disease in the region. We propose that locally developed "warfarin care bundles" which address multiple anticoagulation challenges in combination may be the most appropriate solution in this setting currently.
撒哈拉以南非洲地区的患者通常抗凝控制不佳。我们回顾了导致这种不佳控制的潜在原因以及潜在的解决办法。挑战包括抗凝治疗的可负担性和集中化、药品获取及国际标准化比值监测方面的问题、缺乏经过本地验证的标准化给药方案,以及医护人员和患者的抗凝知识水平较低。由于该地区非传染性疾病负担日益加重,未来将有越来越多的患者需要进行抗凝治疗。我们建议,针对多种抗凝挑战组合而成的本地开发的“华法林护理包”可能是目前这种情况下最合适的解决方案。